(Q34660960)

3 August 2017

1 reference

title

Lipid-based formulations for intestinal lymphatic delivery (English)

1 reference

3 August 2017

Caitriona M O'Driscoll

object named as

Caitriona M O'Driscoll

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmaceutical Sciences

3 August 2017

1 reference

3 August 2017

15

1 reference

3 August 2017

5

1 reference

3 August 2017

405-415

1 reference

Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lipid Digestion and Absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Systemic availability and lymphatic transport of human growth hormone administered by subcutaneous injection

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

The effect of dietary fat load on the size and composition of chylomicrons in thoracic duct lymph

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lipid-based vehicles for the oral delivery of poorly water soluble drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

A proposed model for the assembly of chylomicrons

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Effect of oily vehicles on absorption of mepitiostane by the lymphatic system in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Assembly and secretion of chylomicrons by differentiated Caco-2 cells. Nascent triglycerides and preformed phospholipids are preferentially used for lipoprotein assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Comparison of the lymphatic transport of a lipophilic drug from vehicles containing alpha-tocopherol and/or triglycerides in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Blood and lymph transport of DDT after oral and parenteral administration to anaesthetised rats

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Hepatic canalicular membrane 1: The role of mdr2 P-glycoprotein in hepatobiliary lipid transport

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lymphatic Transport of Halofantrine in the Conscious Rat When Administered as Either the Free Base or the Hydrochloride Salt: Effect of Lipid Class and Lipid Vehicle Dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Alkaline lipase in rat intestinal mucosa: physiological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Chylomicron formation and composition in unanaesthetised rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Deacylation-reacylation cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoylphosphatidylfluorouridine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

A general pattern for substrate recognition by P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Endogenous lipase activity in Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Uptake of fatty acids by jejunal mucosal cells is mediated by a fatty acid binding membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Identification, isolation, and partial characterization of a fatty acid binding protein from rat jejunal microvillous membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Effect of administration route on the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Nutritional control of fatty acid esterification in differentiating Caco-2 intestinal cells is mediated by cellular diacylglycerol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Factors regulating the formation of chylomicrons and very-low-density lipoproteins by the rat small intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Lipoprotein secretion by intestinal Caco-2 cells is affected differently by trans and cis unsaturated fatty acids: effect of carbon chain length and position of the double bond

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Effects of saturated, mono-, and polyunsaturated fatty acids on the secretion of apo B containing lipoproteins by Caco-2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Caco-2 cells secrete two independent classes of lipoproteins with distinct density: effect of the ratio of unsaturated to saturated fatty acid

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900051-9

7 January 2021

10.1016/S0928-0987(02)00051-9

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12036717